|
CSTF2T expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.05749989162985E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06439976224715E-10 |
| Normal-vs-Stage2 |
1.28129999998894E-06 |
| Normal-vs-Stage3 |
6.29309999999883E-07 |
| Normal-vs-Stage4 |
7.6246000000002E-05 |
| Stage1-vs-Stage2 |
8.940600E-01 |
| Stage1-vs-Stage3 |
6.780000E-01 |
| Stage1-vs-Stage4 |
9.697600E-01 |
| Stage2-vs-Stage3 |
8.182000E-01 |
| Stage2-vs-Stage4 |
9.485000E-01 |
| Stage3-vs-Stage4 |
8.011000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09609996026927E-10 |
| Normal-vs-AfricanAmerican |
5.167500000125E-07 |
| Normal-vs-Asian |
4.457200E-03 |
| Caucasian-vs-AfricanAmerican |
4.613400E-01 |
| Caucasian-vs-Asian |
7.696600E-01 |
| AfricanAmerican-vs-Asian |
9.719000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.94098079223204E-12 |
| Normal-vs-Female |
7.95920000000727E-05 |
| Male-vs-Female |
2.681900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.66770000534322E-08 |
| Normal-vs-Extreme_Weight |
1.60830015971669E-10 |
| Normal-vs-Obese |
2.51799999961833E-07 |
| Normal-vs-Extreme_Obese |
1.5274899999973E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.238000E-01 |
| Normal_Weight-vs-Obese |
1.983570E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.273800E-01 |
| Extreme_Weight-vs-Obese |
6.270000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.036800E-01 |
| Obese-vs-Extreme_Obese |
2.729600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.022160E-04 |
| Normal-vs-Age(41-60Yrs) |
3.95060000268899E-08 |
| Normal-vs-Age(61-80Yrs) |
3.83669762626937E-11 |
| Normal-vs-Age(81-100Yrs) |
3.08109999735962E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.847800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.916100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.160120E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.432300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.524200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.271200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.48680001643697E-09 |
| Normal-VS-Type2 PRCC |
1.99540051148972E-10 |
| Normal-VS-KIRP CIMP |
1.883450E-03 |
| Normal-VS-Unclassified PRCC |
1.015440E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.062800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.124200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.634400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.401600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.429600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.989000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.12527781431982E-13 |
| Normal-vs-N1 |
6.203000E-04 |
| Normal-vs-N2 |
3.723600E-03 |
| N0-vs-N1 |
2.105900E-02 |
| N0-vs-N2 |
8.110800E-01 |
| N1-vs-N2 |
4.013400E-01 |
|
|
